Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : PTE source : Www.biospace.com save search
PolarityTE to Present at the H.C. Wainwright 24th Annual Global Investment Conference on September 14, 2022
Published: 2022-09-13 (Crawled : 13:20) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 0.35%
H: 13.98%
C: 8.06%
global conference
PolarityTE to Report Q2 2022 Financial Results on August 11, 2022
Published: 2022-08-01 (Crawled : 14:00) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 0.0%
H: 1.49%
C: 0.75%
report results
PolarityTE Announces FDA Regenerative Medicine Advanced Therapy Designation Granted to SkinTE®
Published: 2022-05-13 (Crawled : 12:20) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 92.39%
H: 0.0%
C: 0.0%
skinte fda designation granted therapy grant
PolarityTE Announces First Subject Enrolled in Phase III Pivotal Study Evaluating Investigational New Drug SkinTE® in Diabetic Foot Ulcers
Published: 2022-05-03 (Crawled : 18:00) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: -1.04%
H: 14.36%
C: 3.87%
skinte drug diabetic enroll
Stella Diagnostics Announces Leadership Changes: Dr. Joe Abdo Assumes a New Role as Chief Scientific Officer, and Director David Seaburg is Appointed Chief Executive Officer
Published: 2022-04-22 (Crawled : 14:20) - biospace.com/
SLDX | $0.0633 416.75% 230
|
Information
|
| O: 34.82%
H: 2.1%
C: 2.1%
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 2.19%
H: 7.95%
C: -1.1%
diagnostics diagnostic
PolarityTE Announces $5.0 Million Registered Direct Offering
Published: 2022-03-16 (Crawled : 13:30) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: -13.97%
H: 19.83%
C: 14.03%
offering
PolarityTE Announces Allowance of Fourth U.S. Patent
Published: 2022-02-17 (Crawled : 14:30) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: -0.02%
H: 2.24%
C: -3.18%
ces patent
PolarityTE Announces U.S. FDA Approval of IND for Pivotal Phase 3 Study of SkinTE® to Support Chronic Cutaneous Ulcer Indication
Published: 2022-01-18 (Crawled : 15:00) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 3.81%
H: 11.07%
C: -3.92%
skinte fda fda approval skin approval phase 3
PolarityTE Announces Submission of Complete Response to FDA's Clinical Hold Correspondence for SkinTE® Investigational New Drug Application
Published: 2021-12-20 (Crawled : 14:30) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 2.56%
H: 8.75%
C: 8.7%
skinte clinical hold new drug fda application drug skin pons submission response
PolarityTE to Report Third Quarter Financial Results on November 10, 2021
Published: 2021-10-28 (Crawled : 13:00) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: -2.73%
H: 6.32%
C: 5.94%
financial results results
PolarityTE Provides Update on Investigational New Drug Application
Published: 2021-10-07 (Crawled : 13:00) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 1.76%
H: 5.58%
C: -0.27%
new drug drug application
PolarityTE Provides Update on U.S. FDA Investigational New Drug Application for SkinTE®
Published: 2021-08-24 (Crawled : 13:00) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: -22.37%
H: 18.5%
C: 17.25%
new drug fda drug skin application
PolarityTE Submits Investigational New Drug Application for SkinTE® in Chronic Cutaneous Ulcers
Published: 2021-07-26 (Crawled : 13:00) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 3.21%
H: 0.62%
C: -2.53%
new drug drug skin application
PolarityTE Announces Diabetic Foot Ulcer Trial Met Primary and Secondary Endpoint
Published: 2021-05-10 (Crawled : 16:00) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 29.34%
H: 9.52%
C: -4.76%
trial diabetic diabetes
PolarityTE to Report First Quarter Financial Results on May 13, 2021
Published: 2021-05-03 (Crawled : 13:00) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 1.96%
H: 0.0%
C: -1.92%
financial results results
PolarityTE to Report Fiscal Year 2020 Financial Results on March 30, 2021
Published: 2021-03-10 (Crawled : 18:01) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 0.0%
H: 4.32%
C: -7.91%
financial results results
PolarityTE Provides Corporate Update
Published: 2021-02-10 (Crawled : 15:00) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 2.6%
H: 4.43%
C: 3.8%
PolarityTE, Inc. Announces Exercise of Warrants for Gross Proceeds of $7.67 Million
Published: 2021-01-22 (Crawled : 15:00) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 0.0%
H: 0.93%
C: -2.78%
PolarityTE Announces Completion of Target Enrollment in Diabetic Foot Ulcer Trial
Published: 2021-01-21 (Crawled : 15:00) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 0.93%
H: 4.63%
C: 0.0%
trial diabetic diabetes enroll
PolarityTE Announces Closing of $10.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Published: 2021-01-14 (Crawled : 22:00) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 14.78%
H: 0.76%
C: -8.33%
offering nasdaq
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.